Intrathecal baclofen for treating spasticity in children with cerebral palsy

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 11, 2015, Pages

  Hasnat, Monika J ^a   Rice, James E ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b Women's and Children's Health Network   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; PLACEBO; CENTRAL MUSCLE RELAXANT;

CEREBRAL PALSY; CHILD; CLINICAL OUTCOME; COMFORT; DRUG EFFECT; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH ECONOMICS; HUMAN; LONG TERM CARE; LUMBAR PUNCTURE; METHODOLOGY; MOTOR PERFORMANCE; ORTHOPEDIC SURGERY; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; REVIEW; SAMPLE SIZE; SHORT COURSE THERAPY; SPASTICITY; STATISTICAL BIAS; SYSTEMATIC REVIEW; VALIDATION STUDY; ADOLESCENT; COMPLICATION; INTRASPINAL DRUG ADMINISTRATION; MUSCLE SPASTICITY; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; BACLOFEN; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; HUMANS; INJECTIONS, SPINAL; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84964695817     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004552.pub2     Document Type: Review

References (203)

1. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991;265(11):1418-22.
2. Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. Journal of Neurosurgery 1997;87:409-14.
3. Gilmartin R, Bruce D, Storrs BB, Abbott R, Krach L, Ward J, et al. Intrathecal baclofen for management of spastic cerebral palsy: multicentre trial. Journal of Child Neurology 2000;15(2):71-7.
4. Hoving MA, van Kranen-Mastenbroek VHJM, van Raak EPM, Spincemaille GHJJ, Hardy ELM, Vles JSH. Placebo controlled utility and feasibility study of the H-reflex and flexor. Clinical Neurophysiology 2006;117:1508-17.
5. Hoving MA, van Raak EPM, Spincemaille GHJJ, Palmans LJ, Sleypen FAM, Vles JSH. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomised, placebo-controlled dose finding study. Developmental Medicine and Child Neurology 2007;49:654-9.
6. Hoving MA, van Raak EPM, Spincemaille GHJJ, Palmans LJ, Becher JG, Vles JSH. Efficacy of intrathecal baclofen therapy in children with intractable cerebral palsy: a randomised controlled trial. European Journal of Neurology 2009;13:240-6.
7. Albright AL, Barron WB, Fasick MP, Polinko P, Jonosky J. Continuous intrathecal baclofen for spasticity of cerebral origin. JAMA 1993;270(20):2475-7.
8. Albright LA, Barry MJ, Fasick MP, Janosky J. Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity. Pediatric Neurosurgery 1995;23:82-5.
9. Albright LA, Barry MJ, Painter MJ, Shultz B. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. Journal of Neurosurgery 1998;88:73-6.
10. Albright AL, Shafron DH, Barry MJ. Intrathecal baclofen for the treatment of severe generalised dystonia. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2000. 2000; Vol. 83.
11. Albright AL, Barry MJ, Shafron DH, Ferson SS. Intrathecal baclofen for generalised dystonia. Developmental Medicine and Child Neurology 2001;43:652-7.
12. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. Journal of Neurosurgery 2003;98:291-5.
13. Albright AL, Awaad Y, Muhonen MB, Boydston WR, Gilmartin R, Krach LE, et al. Performance and complications associated with the SynchroMed 10-ml infusion pump for intrathecal baclofen administration in children. Journal of Neurosurgery 2004;101:64-8.
14. Albright AL, Ferson SS. Intrathecal baclofen therapy in children. Neurosurgical Focus 2006;21(2):e3.
15. Aldahondo N, Krach LE. Priapism as a sign of intrathecal baclofen withdrawal: a case series. Developmental Medicine and Child Neurology. 2013; Vol. 55, issue s3:61-2.
16. Aleton E, Decavel P, Michel F, Bevalot J, Godard J, Parratte B. Intrathecal baclofen for spasticity management: A comparative analysis of complications in a series of 88 pumps for adults and children [Intrathecal baclofen for spasticity management: A comparative analysis of complications in a series of 88 pumps for adults and children]. Annals of Physical and Rehabilitation Medicine. October 2012; Vol. 55:e336-9.
17. Almeida GL, Campbell SK, Girolami GL, Penn RD, Corcos DM. Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen. Physical Therapy 1997;77(7):751-64.
18. Anonymous Intrathecal baclofen for cerebral spasticity. American Family Physician 1996;54(5):1808.
19. Awaad Y, Ham S, Chinarian J, Tayem H, Munoz S. Intrathecal baclofen therapy for the treatment of spasticity in children with cerebral palsy. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2000. 2000; Vol. 84.
20. Awaad Y, Tayem H, Munoz S, Ham S, Michon AM, Awaad R. Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. Journal of Child Neurology 2003;18:26-34.
21. Ayyangar R, Bukrey SL, Warschausky SA, Hurvitz EA. Use of the modified Ashworth score as a selection criterion for intrathecal baclofen therapy: is it a useful predictor of long-term functional gain?. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2002. 2002; Vol. 91.
22. Ayyangar R, Fox M, McCoy A. Weight gain in children receiving intrathecal baclofen therapy for management of cerebral origin spasticity. Developmental Medicine and Child Neurology - Supplementum. Abstract of the 59th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2005. 2005; Vol. 102.
23. Ayyangar E, Enebak L, Garton H, Fox M. Relationshp between health-related quality of life, spasticity and function in children with cerebral palsy undergoing intrathecal baclofen therapy. Developmental Medicine and Child Neurology. 2007; Vol. 49, issue s111:2.
24. Ayyangar R, Fox MA, Warschausky SA, Giordani B, Garton H, Damodaran A. Cognitive effects of intrathecal baclofen therapy in adolescents with cerebral palsy. Developmental Medicine and Child Neurology. 2011; Vol. 53, issue s5:7-8.
25. Baker L, Eldridge B, Randall M, Petersen S, Wray A, Antolovich G. Management of acute intrathecal baclofen withdrawal. Developmental Medicine and Child Neurology. 2012; Vol. 54, issue s5:75.
26. Barry MJ. Predictors of success of intrathecal baclofen for ease of care and comfort. Dissertation, School of Health and Rehabilitation Sciences, University of Pittsburgh 2001.
27. Bensmail D, Quera Salva MA, Roche N, Benyahia S, Bohic M, Denys P, et al. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity. Neurology 2006;67:1432-6.
28. Bensmail D, Ward Ab, Wissel J, Motta F, Saltuari L, Lissens J, et al. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity. Neurorehabilitation and Neural Repair 2009;23(6):546-52.
29. Bjornson KF, McLaughlin JF, Loeser JD, Nowak-Cooperman KM, Russel M, Bader K, et al. Oral motor, communication and nutritional status of children during intrathecal baclofen therapy: a descriptive pilot study. Archives of Physical Medicine and Rehabilitation 2003;84:500-6.
30. Bleichman J, Bode R, Gaebler-Spira D, Tann B. Weight gain in patients with cerebral palsy following implantation of intrathecal baclofen infusion pumps. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 55th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2001. 2001; Vol. 88.
31. Bleichman J, Bode R, Gaebler-Spira D, Tann B. Weight gain in patients with cerebral palsy following implantation of intrathecal baclofen infusion pumps. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2002. 2002; Vol. 91.
32. Bleyenheuft C, Filipetti P, Caldas C, Lejeune T. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy. Neurophysiologie Clinique 2007;37(1):23-8.
33. Bollo RJ, Gooch JL, Walker ML. Sterotactic endosccopic placement of third ventricle catheter for long term infusion of intrathecal baclofen in patients with secondary generalised dystonia. Journal of Neurosurgery Pediatrics 2012;10:30-3.
34. Borowski A, Littleton AG, Dabney KW, Miller F. Baclofen pump implantation and spinal fusions in children: does order or timing influence complications?. Developmental Medicine and Child Neurology. 2007; Vol. 49:2-3.
35. Borowski A, Shah SA, Littleton AG, Dabney KW, Miller F. Baclofen pump implantation and spinal fusion in children. Spine 2008;33:1995-2000.
36. Borowski A, Littleton AG, Borkhuu B, Presedo A, Shah S, Dabney KW, et al. Complications of intrathecal baclofen pump therapy in pediatric patients. Journal of Pediatric Orthopedics 2010;30:76-81.
37. Bourg V, Lazorthes Y, Sallerin B. Implantation of an intrathecal baclofen pump in children with cerebral palsy: The results from a two year follow up of a multicentre study. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the European Academy of Childhood Disability Annual Meeting 2005. 2005; Vol. 103.
38. Bragg TM, Meyer E. Intraventricular baclofen for the treatment of secondary dystonia and spasticity: clinical outcomes, dosing and side effects. Developmental Medicine and Child Neurology. 2013; Vol. 55, issue s3:9.
39. Brochard S, Remy-Neris O, Filipetti P, Bussel B. Intrathecal baclofen infusion for ambulant children with cerebral palsy. Pediatric Neurology 2009;40:265-70.
40. Brochard S, Lempereur M, Filipetti P, Remy-Neris O. Changes in gait following continuous intrathecal baclofen infusion in ambulant children and young adults with cerebral palsy. Developmental Neurorehabilitation 2009;12(6):397-405.
41. Broseta J, Garcia-March G, Sanchez-Ledesma MJ, Anaya J, Silva I. Chronic intrathecal baclofen administration in severe spasticity. Stereotactic and Functional Neurosurgery 1990;54:147-53.
42. Burn S, Zeller R, Drake JM. Do baclofen pumps influence the development of scoliosis in children?. Journal of Neurosurgery 2010;5:195-9.
43. Cabrera MN, Snow S, Smith BP, Koman LA, Shilt JS. Acute effects of intrathecal baclofen on spinal deformity in patients with cerebral palsy. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 58th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2004. 2004; Vol. 99.
44. Caird MS, Palanca AA, Garton H, Hensinger RN, Ayyangar RN, Drongowski A, et al. Outsomes of posterior spinal fusion and instrumentation in patients with continuous intrathecal baclofen infusion pumps. Spine 2008;33:E94-9.
45. Campbell W, Grant G, McLaughlin J, Bjornson K, Loeser J, Ferrel A, et al. Continuous intrathecal baclofen infusion in children and adolescents with spasticity of cerebral origin. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 1999. 1999; Vol. 80.
46. Campbell WM, Ferrel A, McLaughlin JF, Grant GA, Loeser JD, Graubert C, et al. Long-term safety and efficacy of continuous intrathecal baclofen. Developmental Medicine and Child Neurology 2002;44(10):660-5.
47. Charles DP, Gill CE, Taylor HM, Putman MS, Blair CL, Roberts AG, et al. Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability. Movement Disorders 2010;25(4):466-73.
48. Church C, Quaile K, Lyons S, Miller F. The effect of intrathecal baclofen on ambulation. Developmental Medicine and Child Neurology. 2008; Vol. 50, issue s5:37.
49. Concalves J, Garcia-March G, Sanchez-Ledesma MJ, Onzain I, Broseta J. Management of intractable spasticity of supraspinal origin by chronic cervical intrathecal infusion of baclofen. Sterotactic and Functional Neurosurgery 1994;62:108-12.
50. Creedon SD, Dijkers PJM, Hinderer SR. Intrathecal baclofen for severe spasticity: a meta-analysis. International Journal of Rehabilitation and Health 1997;3(3):171-85.
51. Dachy B, Dan B. Electrophysiological assessment of intrathecal baclofen in dystonic children. Clinical Neurophysiology 2004;115:774-8.
52. Damiano DL, Gilgannon MD, Abel MF. Responsiveness and uniqueness of the pediatric outcomes data collection instrument compared to the gross motor function measure for measuring orthopaedic and neurosurgical outcomes in cerebral palsy. Journal of Pediatric Orthopaedics 2005;25(5):641-5.
53. Dickey MP, Rice M, Kinnet DG, Lambert R, Donauer S, Gerber MA, Staat MA. Infectious complications of intrathecal baclofen pumps in a paediatric population. The Pediatric Infectious Diseases Journal 2013;32(7):715-22.
54. Eldridge B, Pearce L, Petersen S, Antolovich G, Wray A, Randall M. The efficacy of intrathecal baclofen therapy on children and adolescents with complex movement disorders of neurological origin. Developmental Medicine and Child Neurology. 2012; Vol. 54:65.
55. Emery E. Intrathecal baclofen. Literature review of the results and complications [Baclofene intrathecal. Analyse de la literature des resultats et des complications]. Neurochirurgie 2003;49(2-3):276-88.
56. Ethans KD, Schryvers OI, Nance PW, Casey AR. Intrathecal drug therapy using Codman model 3000 constant flow implantable infusion pumps: experience with 17 cases. Spinal Cord 2005;43:214-8.
57. Fares Y, del Barrio ER, Burzaco JA. El uso intratecal de baclofen en el tratamiento de las espasticidad rebelde, moldes y resultados. Dolor 1999;14:291-9.
58. Fares Y, Kasim RM, del Barrio ER, Burzaco JA. Dosage of intrathecal baclofen maintenance therapy in the spastic syndromes. Lebanese Medical Journal 2004;52(1):13-8.
59. Farfara A, Kwiatkowski S, Kawecka J, Grzegorzewski P, Kawecki Z. The parents expectations after baclofen pump implantation in child with severe spasticity in physical rehabilitation and psychological aspects [Oczekiwania rodzicow po wszczepieniu pompy baclofenowej u dziecka ze spastycznoscia w aspekcie rehabilitacyjynum i psychologicznym]. Przeglad lekarski 2007;64(Suppl 2):18-21.
60. Filipetti P, Caldas C, Delpierre Y. Spasticity management and progress in ambulatory cerebral palsy [Avancees dans le traitement de la spasticite et enfant IMOC]. Archives de Paediatrie 2006;13:614-20.
61. Fitzgerald JJ, Tsegaye M, Vloeberghs MH. Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases. British Journal of Neurosurgery 2004;18(3):240-5.
62. Gerszten PG, Albright AL, Barry MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatric Neurosurgery 1997;27:40-4.
63. Ginsburg GM, Lauder AJ. Progression of scoliosis in spastic quadriplegic patients after insertion of an intrathecal baclofen pump. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2002. 2002; Vol. 91.
64. Ginsburg GM, Lauder AJ. Progression of scoliosis in patients with spastic quadriplegia after the insertion of an intrathecal baclofen pump. Spine 2007;32:2745-50.
65. Giordano F, Gentileschi P. The multidisciplinary network on dystonia and spasticity in children: presentation and first results. Developmental Medicine and Child Neurology. 2011; Vol. 53, issue s3:3-4.
66. Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Care provider assessment of intrathecal baclofen in children. Developmental Medicine and Child Neurology 2004;46(8):548-52.
67. Gray N, Vloeburghs M, Morton R. Monitoring intrathecal baclofen - choosing the right outcome measure. Developmental Medicine and Child Neurology. 2007; Vol. 49, issue s111:11-2.
68. Gutierrez-Solana LG, Ruiz-Falco ML, Perez-Diaz C. Intrathecal baclofen therapy: the selection of patients and short term results in five patients [Terapia con baclofen intratecal: Seleccion de pacientes y resultados a corto plazo en cinco pacientes]. Revista de Neurolgia 2003;37(1):83-5.
69. Hagglund G, Anderssson S, Duppe H, Pedertsen HL, Nordmark E, Westborn L. Prevention of severe contractures might replace multilevel surgery in cerebral palsy: results of a population based health care programme and new techniques to reduce spasticity. Journal of Pediatric Orthopaedics 2005;14:269-73.
70. Haranhalli N, Anand D, Wisoff JH, Harter DH, Weiner HL, Blate M, Roth J. Intrathecal baclofen therapy: complication avoidance and management. Childs Nervous System 2011;27:421-7.
71. Henry-Socha N, Aldahondo N, Kim PD, Krach E. Unusual complication of intrathecal baclofen pump and catheter placement in a child with cerebral palsy: a case report. 2012 American Academy of Physical Medicine and Rehabilitation, AAPM&R Annual Assembly. Conference Publication. 2012; Vol. 4:S343.
72. Hester SM, Fisher JF, Lee MR, Macomsen S, Vender JR. Evaluation of salvage techniques for infected baclofen pumps in paediatric patients with cerebral palsy. Journal of Neurosurgery Pediatrics 2012;10:548-54.
73. Hoving MA, Evers SMA, Ament AJHA, van Raak EPM, Vles JSH. Intrathecal baclofen therapy in children with intractable cerebral palsy: a cost-effectiveness analysis. Developmental Medicine and Child Neurology 2008;50:450-5.
74. Hoving MA, van Raak EPM, Spincemaille GHJJ, van Kranen-Masternbroek VHJM, van Kleef M, Gorter JW, et al. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. European Journal of Paediatric Neurology 2009;13:247-56.
75. Kashii H, Ando A, Terashima H, Ota S, Kubota M, Morota N. Current status of intrathecal baclofen therapy for children with severe spasticity and/or dystonia. Developmental Medicine and Child Neurology. 2012; Vol. 54:117-8.
76. Kolaski K, Logan LR. A review of the complications of intrathecal baclofen in patients with cerebral palsy. NeuroRehabilitation 2007;22:383-95.
77. Krach LE, Gilmartin R, Bruce D, Storrs B, Abbott R, Ward J, et al. Functional changes noted following treatment of individuals with cerebral palsy with intrathecal baclofen. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 1997. 1997; Vol. 75.
78. Krach LE. Management of intrathecal baclofen withdrawal: A case series. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 1999. 1999; Vol. 80.
79. Krach LE. Complications associated with continuous infusion of intrathecal baclofen. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 1999. 1999; Vol. 80.
80. Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R, et al. Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion. Pediatric Neurology 2004;30:163-8.
81. Krach LE, Walker K, Kapp L. Comparison of mortality in case-matched individuals with cerebral palsy receiving versus not receiving intrathecal baclofen. Developmental Medicine and Child Neurology - Supplementum. Abstract of the 59th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine. 2005; Vol. 102.
82. Krach L, Nugent A, Rapp L, Kempla B, Nettleton A. Use of medication after orthopaedic surgery: comparison of children with cerebral palsy with and without intrathecal baclofen. Neurorehabilitation and Neural Repair. 2005; Vol. 19, issue 4:362.
83. Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbot R, et al. GMFM 1 year after continuous intrathecal baclofen infusion. Pediatric Rehabilitation 2005;8(3):207-13.
84. Krach LE, Walker K, Rapp L. The effect of intrathecal baclofen treatment on the development of scoliosis in individuals with cerebral palsy: a retrospective, case-matched review. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 59th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2005. 2005; Vol. 102.
85. Krach LE, Nettleton A, Klempka B. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump. Pediatric Rehabilitation 2006;9(3):210-8.
86. Krach LE. Intrathecal baclofen use in adults with cerebral palsy. Developmental Medicine and Child Neurology 2009;51(Supplement 4):106-12.
87. Krach LE, Kriel R, Day SM, Strauss DJ. Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched cohort study. Developmemental Medicine and Child Neurology 2010;52:672-6.
88. Krach LE, Kriel RL, Day SM. Survival following intrathecal baclofen pump implantation. Developmental Medicine and Child Neurology. 2008; Vol. 50:36-7.
89. Latash ML, Penn RD. Changes in voluntary motor control induced by intrathecal baclofen in patients with spasticity of different etiology. Physiotherapy Research International 1996;1(14):229-46.
90. Lazothes Y, Sallerin-Caute B, Verdie JC, Bastide R, Carillo JP. Chronic intrathecal baclofen administration for control of severe spasticity. Journal of Neurosurgery 1990;72:393-402.
91. Leslie DP, Ahrendt L. Managing severe spasticity with intrathecal baclofen (ITB) therapy. Journal of Care Management 1999;Special Edition:21-6.
92. Martinez Moreno M, Moraleda-Perez S, Deiana A, Pascual-Pascual S. Psychotic symptoms associated to intrathecal baclofen infusion. Developmental Medicine and Child Neurology. 2013; Vol. 55, issue s2:44.
93. McCoy RN, Blasco PA, Russman BS, O'Malley JP. Validation of a care and comfort hypertonicity questionnaire. Developmental Medicine and Child Neurology 2006;48(3):181-7.
94. McCoy AA, Fox MA, Schaubel DE, Ayyangar RN. Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy. Archives of Physical Medicine and Rehabilitation 2006;87:1503-8.
95. McMahon MA, Kinnett DG, Bailes AF, Bean J. Intrathecal baclofen therapy effects on health-related quality of life, gross-motor function and caregiver assistance in children with spasticity of cerebral origin. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 57th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2003. 2003; Vol. 96.
96. Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Archives of Physical Medicine and Rehabilitation 2001;82:155-61.
97. Moosa A, Ghosh D, Khera J, Luciano M. Intrathecal baclofen pump in children with CSF shunting. Developmental Medicine and Child Neurology. 2008; Vol. 50, issue s4:37-8.
98. Morton RE, Gray N, Vloeburghs M. Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy. Developmental Medicine and Child Neurology 2011;53(8):736-41.
99. Motta F, Galli M, Sibella F, Crivellini M. The effect of intrathecal baclofen therapy on gait in children with cerebral palsy. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2000. 2000; Vol. 83.
100. Motta F, Buonaguro V, Carletti T, Galli E. Intrathecal baclofen therapy (ITBT) in children affected by spastic diplegia. A comparison of results among gait analysis, functional and subjective patient evaluations. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 55th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2001. 2001; Vol. 88.
101. Motta F, Buonaguro V, Galli E. Intrathecal baclofen therapy in children affected by spastic diplegia. A comparison of results among gait analysis, functional and participative patient evaluations. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2002. 2002; Vol. 91.
102. Motta F, Stignani, Buonaguro V, Abramini M. Effect of intrathecal baclofen on upper limb function in cerebral palsy. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 58th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2004. 2004; Vol. 99.
103. Motta F, Buonaguro V, Stignani C, Condurso F. Functional assessment of children with dystonia before and after intrathecal baclofen therapy. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 58th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2004. 2004; Vol. 99.
104. Motta F, Buonaguro V, Stignani C. The use of intrathecal baclofen in children and adolescents: safety and complications in 200 consecutive cases. Journal of Neurosurgery 2007;107:32-5.
105. Motta F, Stignani C, Antonello CE. Upper limb function after intrathecal baclofen treatment in children with cerebral palsy. Journal of Pediatric Orthopedics 2008;28(1):91-6.
106. Motta F, Antonello CE, Stignani C. Upper limb function after intrathecal baclofen therapy in children affected by secondary dystonia. Developmental Medicine and Child Neurology. 2009; Vol. 51, issue s5:6-7.
107. Motta F, Antonello C, Stignani C. Intrathecal baclofen and motor function in cerebral palsy. Developmental Medicine and Child Neurology 2011;53:443-8.
108. Mukherjee S, Taylor S, Gaebler-Spira D. Changes in seating needs and complications after intrathecal baclofen pump therapy. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2002. 2002; Vol. 91.
109. Muquit S, Ugratdhar I, Ingale H, Vloeberghs Cervical catheter placement for intrathecal baclofen test dose: is it safe?. Childs Nervous System 2012;28:919-22.
110. Murphy NA, Irwin MCN, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Archives of Physical Medicine and Rehabilitation 2002;83:1721-5.
111. Najarian CR, Taniguchi M, Krach LE, Stansbury J, Bonau T, Partington M. Catheter access port aspiration to assess intrathecal baclofen withdrawal. Developmental Medicine and Child Neurology. 2012; Vol. 54, issue s6:3-4.
112. Ochs Ga, Tonn JC. Functional outcome and clinical significance of long-term intrathecal baclofen therapy for severe spasticity. Journal of Neurological Rehabilitation 1996;10:159-66.
113. Penn RD, Gianino JM, York MM. Intrathecal baclofen for motor disorders. Movement Disorders 1995;10(5):675-7.
114. Piccinini L, Krach LE, Gage J, Novacheck T. Gait and functional evaluation pre and post intrathecal baclofen pump implantation. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 1999. 1999; Vol. 80.
115. Piccinini L, Maghini C, Germiniasi C, Beretta E. EEG anomalies after intrathecal baclofen vs oral treatment in children affected by cerebral palsy. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 55th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2001. 2001; Vol. 88.
116. Pin TW, McCartney L, Lewis J, Waugh MC. Use of intrathecal baclofen in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review. Developmental Medicine and Child Neurology 2011;53:885-95.
117. Pritula SL, Fox MA, Ayyangar R. Weight changes in children receiving intrathecal baclofen for the treatment of spasticity. Journal of Pediatric Rehabilitation Medicine 2012;5(3):197-201.
118. Ramstad K, Jahnsen R, Lofterod B, Skjeldal OH. Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?. Acta Paediatrica 2010;99:1661-5.
119. Rawicki B. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: Long-term follow-up review of 18 patients. Journal of Neurosurgery 1999;91:733-6.
120. Revivo G, Tann B, Peng M, Grant J, Gaebler-Spira D. Impact of intrathecal baclofen pump placement on care and comfort measures in children and adults with cerebral palsy. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 55th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2001. 2001; Vol. 88.
121. Revivo G, Tann B, Peng M, Grant J, Gaebler-Spira D. Impact of intrathecal baclofen pump placement on care and comfort measures in children and adults with cerebral palsy. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2002. 2002; Vol. 91.
122. Rippe DM, Tann B, Gaebler-Spira DJ, Krach LE, Gooch J, Dabrowski E. Complications of intrathecal baclofen pump therapy for severe hypertonia in children: a long-term follow-up review of 785 patients from four centres. Developmental Medicine and Child Neurology - Supplementum. Abstract of the European Academy of Childhood Disability Annual Meeting 2005. 2005; Vol. 103.
123. Rippe D, Tann B, Gaebler-Spira D, Krach L, Gooch J, Dabrowski E. Complications of intrathecal baclofen pump therapy for severe hypertonia in children: A long-term follow-up review of 785 patients from four centres. Developmental Medicine and Child Neurology - Supplementum. Abstracts of the 59th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine 2005. 2005; Vol. 102.
124. Saltauri L, Kronenberg M, Marosi MJ, Kofler M, Russegger L, Rifici C, et al. Long-term intrathecal baclofen treatment in supraspinal spasticity. Acta Neurologica 1992;47(3):195-207.
125. Sansone JM, Mann D, Noonan K, Mcleish D, Ward M, Iskandar BJ. Rapid progression of scoliosis following insertion of intrathecal baclofen pump. Journal of Pediatric Orthopedics 2006;26(1):125-8.
126. Saval A, Chiodo AE. Effect of intrathecal baclofen concentration on spasticity control: case series. Journal of Spinal Cord Medicine 2008;31:394-7.
127. Scheinberg AM, O'Flaherty S, Chaseling R, Dexter M. Continuous intrathecal baclofen infusion for children with cerebral palsy: a pilot study. Journal of Paediatrics and Child Health 2001;37:283-8.
128. Seneran H, Shah SA, Presedo A, Dabney KW, Glutting JW, Miller F. The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy. Spine 2007;32:2348-54.
129. Sgouros S, Seri S. The effect of intrathecal baclofen on muscle co-contraction in children with spasticity of cerebral origin. Pediatric Neurosurgery 2002;37(5):225-30.
130. Shilt JS, Lai LP, Cabrera MN, Frino J, Smith BP. The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. Journal of Pediatric Orthopedics 2008;28(6):684-7.
131. Silva S, Nowicki P, Caird MS, Hurvitz EA, Ayyangar RN, Farley FA, et al. A comparison of hip dislocation rates and hip containment procedures after selective dorsal rhizotomy versus intrathecal baclofen pump insertion in nonambulatory cerebral palsy patients. Journal of Pediatric Orthopedics 2012;32:853-56.
132. Simpson RK. Neurological management of chronic pain and spasticity. Critical Reviews in Physical and Rehabilitation Medicine 1999;11:207-27.
133. Sivakumar G, Yap Y, Tsegaye M, Vloeberghs M. Intrathecal baclofen therapy for spasticity of cerebral origin - does the position of the intrathecal catheter matter?. Childs Nervous System 2010;26:1097-102.
134. Staal C, Arends A, Ho S. A self-report of quality of life of patients receiving intrathecal baclofen therapy. Rehabilitation Nursing 2003;28(5):159-63.
135. Steinbok P, Daneshvar H, Evans D, Kestle JRW. Cost analysis of intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy. Pediatric Neurosurgery 1995;22:255-65.
136. Taira T, Ochiai T, Goto S, Hori T. Fifteen year experience of intrathecal baclofen treatment in Japan. Acta Neurochiriguria Supplement 2006;99:61-3.
137. Tasseel Ponche S, Ferrapie A-L, Chenet A, Menei P, Gambart G, Menegalli Bogeli D, et al. Intrathecal baclofen in cerebral palsy. A retrospective study of 25 wheelchair-assisted adults [Baclofene intrathecal dans le paralysie cerebrale. Etude retrospective de 25 patients adultes non marchants]. Annals of Physical and REhabilitation Medicine 2010;53:483-98.
138. Turner M, Nguyen HS, Cohen-Gadol Aaron. Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations. Journal of Neurosurgery Pediatrics 2012;10:315-9.
139. Ughratadar I, Muquit I, Ingale H, Moussa A, Ammar A, Vloeberghs M. Cervical implantation of intrathecal baclofen pump catheter in children with severe scoliosis. Journal of Neurosurgery Pediatrics 2012;10:34-8.
140. Ushewokunze S, Antolovich G, Eldridge B, Randall M, Petersen S, Wray A. Intrathecal baclofen use in children with hemidystonia - a series of four cases. Developmental Medicine and Child Neurology. 2012; Vol. 54:65.
141. Van Hulst BM, Tel PA, De Groot V, Van Ouwerkerk WJR, Vermeulen RJ, Becher JG, Peerdeman SM. Complications of intrathecal baclofen therapy in children and related caregiver satisfaction [Complicaties bij kinderen met intrathecale baclofentherapie en (gerelateerde) verzorgertevredenheld]. Tijdschrift voor Kindergeneeskunde 2009;77(5):191-7.
142. Van Schaeybroek P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled double-blind study. Congress of Neurological Surgeons 2000;46(3):603-12.
143. Van Schie PEM, Becher JG, Vermeulen RJ. The influence of intrathecal baclofen therapy (ITB) on the need for care of children with general dystonia. Developmental Medicine and Child Neurology - Supplementum. European Academy of Child Disability Annual Meeting Abstracts 2001. 2001; Vol. 89.
144. Vitztum C, Olney B. Intrathecal baclofen therapy and the child with cerebral palsy. Orthopaedic Nursing 2000;19(1):43-8.
145. Vloeberghs M, Keetley R, Morton R. Intrathecal baclofen in the management of spasticity due to cerebral palsy. Pediatric Rehabilitation 2005;8(3):172-9.
146. von Koch CS, Park TS, Steinbok P, Smyth M, Peacock WJ. Selective posterior rhizotomy and intrathecal baclofen for the treatment of spasticity. Pediatric Neurosurgery 2001;35:57-65.
147. Ward A, Hayden S, Dexter M, Scheinberg A. Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment. Journal of Paediatrics and Child Health 2009;45:720-6.
148. Wunderlich CA, Krach LE. Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study. Developmental Medicine and Child Neurology 2006;48:450-5.
149. Zdolsek HA, Olesch C, Antolovich G, Reddihough G. Intrathecal baclofen therapy: benefits and complications. Journal of Intellectual and Developmental Disability 2011;36(3):207-13.
150. Zierski J, Dralle D, Wurdinger T. Implanted pump systems for treatment of spasticity. Acta Neurochirurgica 1988;94(Suppl 43):93-9.
151. Aitken RCB. Measurement of feelings using visual analogue scales. Proceedings of the Royal Society of Medicine 1969;62:989-93.
152. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-3.
153. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy 1987;67(2):206-7.
154. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European Journal of Neurology 1999;6(Suppl 4):S23-35.
155. Brashear A, Zafonte R, Corcoran M, Galvez-Jiminez N, Gracies JM, Gordon, et al. Inter- and intrarater reliability of the Ashworth scale and the disability assessment scale in patients with upper limb poststroke spasticity. Archives of Physical Medicine and Rehabilitation 2002;83:1349-54.
156. Clopton N, Dutton J, Featherston T, Grigsby A, Mobley J, Melvin J. Interrater and intrarater reliability of the modified Ashworth scale in children with hypertonia. Pediatric Physical Therapy 2005;17:268-74.
157. Damiano DL, Quinlivan JM, Owen BF, Payne P, Nelson KC, Abel MF. What does the Ashworth scale really measure and are instrumented measures more valid and precise?. Developmental Medicine and Child Neurology 2002;44:112-8.
158. Davidoff RA. Antispasticity drugs: Mechanisms of action. Annals of Neurology 1985;17:107-16.
159. Davis E, Shelly A, Waters E, Davern M. Measuring the quality of life of children with cerebral palsy: comparing the conceptual differences and psychometric properties of three instruments. Developmental Medicine and Child Neurology 2010;52:174-80.
160. de Boer AG, van Lanschot JJ, Stalmeier PF, van Sandick JW, Hulscher JBF, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?. Quality of Life Research 2004;12(2):311-20.
161. de Lissovoy G, Matza LS, Green H, Werner M, Edgar T. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy. Journal of Child Neurology 2007;22(1):49-59.
162. Dietz V. Supraspinal pathways and the development of muscle-tone dysregulation. Developmental Medicine and Child Neurology 1999;41:708-15.
163. Fosang AL, Galea MP, McCoy AT, Reddihough DS, Story I. Measures of muscle and joint performance in the lower limb of children with cerebral palsy. Developmental Medicine and Child Neurology 2003;45:664-70.
164. Gerszten PC, Albright AL, Johnstone GF. Intrathecal baclofen infusion and subsequent orthopaedic surgery in patients with spastic cerebral palsy. Journal of Neurosurgery 1998;88:1009-13.
165. Haas BM, Bergstrom E, Jamous A, Bennie A. The inter rater reliability of the original and of the modified Ashworth scale for the assessment of spasticity in patients with spinal cord injury. Spinal Cord 1996;34(9):560-4.
166. Hagberg B, Hagberg G, Olow I. The changing panorama of cerebral palsy in Sweden: VI. Prevalence and origin during birth year period 1983-1986. 1993 82;4:387-93.
167. Hagberg B, Hagberg G, Beckung E, Uvebrant P. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94. Acta Paediatrica 2001;90:271-7.
168. Haley SM, Coster WJ, Ludlow LH, et al. Paediatric Evaluation of Disability Inventory (PEDI): Version 1. New England Medical Centre - PEDI Research Group 1992.
169. Hayley SM, Coster, WI, Kao YC, Dumas HM, Fragala-Pinkham MA, Kramer JM, et al. Lessons from Use of the PediatricEvaluation of Disability Inventory:Where Do We Go from Here. Pediatric Physical Therapy 2010;22:69-75.
170. Himmelmann K, Uvebrant P. The panorama of cerebral palsy in Sweden. XI. Changing patterns in the birth-year period 2003-2006. Acta Pædiatrica 2014;103:618-624.
171. Hugenholtz H, Nelson RF, Dehoux E, Bickerton R. Intrathecal baclofen for intractable spinal spasticity: a double-blind cross-over comparison with placebo in 6 patients. Canadian Journal of Neurological Sciences 1992;19:188-95.
172. Jaeschke R, Singer J, Guyatt GH. A comparison of seven-point and visual analogue scales. Controlled Clinical Trials 1990;11(1):43-51.
173. Knuttson E, Lindblom U, Beissinger RL, Martensson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimum therapeutic responses in spastic paresis. Journal of Neurological Sciences 1974;23:473-84.
174. Landgraf JM, Abetz L, Ware JE. Child Health Questionnaire (CHQ): A User's Manual. Health Institute, New England Medical Center, 1996.
175. Loeters MJB, Maathuis CGB, Hadders-Algrra M. Risk factors for emergence of scoliosis in children with cerebral palsy: a systematic review. Developmental Medicine and Child Neurology 2010;52:605-11.
176. Lonstein JE, Akbarnia A. Operative treatment of spinal deformities in patients with cerebral palsy or mental retardation. Journal of Bone and Joint Surgery, America 1983;65(1):43-55.
177. Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen: long term effects on spasticity in spinal cord injury. Paraplegia 1991;29:48-64.
178. Mackey AH, Walt SE, Lobb, G, Stott S. Intraobserver reliability of the modified Tardieu scale in the upper limb of children with hemiplegia. Developmental Medicine and Child Neurology 2004;46:267-72.
179. McCullough N, Parkes J. Use of the Child Health Questionnaire in children with cerebral palsy: A systematic review and evaluation of psychometric properties. Journal of Paediatric Psychology 2009;33(1):80-90.
180. Oeffinger D, Bagley A, Rogers S, Gorten G, Kryscio R, Abel M, et al. Outcome tools used for ambulatory children with cerebral palsy: responsiveness and minimally clinically important differences. Developmental Medicine and Child Neurology 2008;50:918-25.
181. Oskoui M, Coutinho F, Dykeman J, Jette N. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Developmental Medicine & Child Neurology 2013;55:509-519.
182. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine and Child Neurology 1997;39:214-23.
183. Pandyan AD, Johnson GR, Price CIM, Curless RH, Barnes MP, Rodgers H. A review of the properties and limitation of the Ashworth and modified Ashworth scales as measures of spasticity. Clinical Rehabilitation 1999;19:373-83.
184. Parkin D, Rice N, Jacoby A, Doughty J. Use of a visual analogue scale in daily patient diary: Modelling cross-sectional time-series data on health-related quality of life. Social Science and Medicine 2004;59(2):351-60.
185. Patrick E, Ada L. The Tardieu scale differentiates contracture from spasticity whereas the Ashworth scale is confounded by it. Clinical Rehabilitation 20;2:173-82.
186. Penn Rd, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984;8385:1078.
187. Reid SM, Carlin JB, Reddihough DS. Distribution of motor types in cerebral palsy: how do registry data compare?. Developmental Medicine & Child Neurology 2011;53:233-238.
188. Reid SM, Carlin JB, Reddihough DS. Rates of cerebral palsy in Victoria, Australia, 1970 to 2004: has there been a change?. Developmental Medicine & Child Neurology 2011;53:907-912.
189. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M. A report: the definition and classification of cerebral palsy. April 2006. Developmental Medicine and Child Neurology 2007;49(s109):8-14.
190. Russell D, Rosenbaum P, Cadman DT, Gowland C, Hardy S, Jarvis S. The Gross Motor Function Measure: a means to evaluate the effects of physical therapy. Developmental Medicine and Child Neurology 1989;31:341-52.
191. Saito N, Ebara S, Ohotsuka K, Kumeta H, Takaoka K. Natural history of scoliosis in spastic cerebral palsy. Lancet 1998;351(9117):1687-92.
192. Sampson FC, Hayward A, Evans G, Morton R, Collett B. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. Journal of Neurosurgery 2002;96:1052.
193. Sandrini G, Serrao M, Rossi P, Romaniello A, Cruccu G, Wiler JC. The lower limb flexor reflex in humans. Progress in Neurobiology 2005;77(6):353-95.
194. Scholtes VB, Becher JG, Beelen A, Lankhorst GJ. Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments. Developmental Medicine and Child Neurology 2006;48:64-73.
195. Sheean G. The pathophysiology of spasticity. European Journal of Neurology 2002;9(Suppl 1):3-9.
196. Singer AJ, Thode HC. Determination of minimally clinically significant difference on patient visual analogue satisfaction scale. Academic Emergency Medicine 1998;5(10):1007-11.
197. Stanley FJ, Alberman E. The epidemiology of the cerebral palsies. Philadelphia: JB Lippincott, 1984.
198. Tyler DC, Tu A, Douthit J, Chapman CR. Towards validation of pain measurement tools for children: A pilot study. Pain 1993;52(3):301-9.
199. Wang HY, Yang YH. Evaluating the responsiveness of 2 versions of the Gross Motor Function Measure for children with cerebral palsy. Archives of Physical Medicine and Rehabilitation 2006;87:51-6.
200. World Health Organization. Towards a common language for functioning, disability and health: ICF. www.who.int/classifications/ICF 2002.
201. Woon K, Tsegaye M, Vloeburghs MH. The role of intrathecal baclofen in the management of primary and secondary dystonia in children. British Journal of Neurosurgery 2007;21(4):355-8.
202. Yam WKL, Leung MSM. Interrater reliability of modified Tardieu scale in children with spastic cerebral palsy. Journal of Child Neurology 2006;21:1031-5.
203. Zieglgansberger W, Howe JR, Sutor B. The neuropharmacology of baclofen. Muller H, Zierski J, Penn RD (Eds) Local Spinal Therapy of Spasticity. Berlin: Springer, 1988.